Expression and secretion of cholera toxin B subunit in lactobacilli

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 6, 2013, Pages 952-958

  Okuno, Takahiro ^a   Kashige, Nobuhiro ^a   Satho, Tomomitsu ^a   Irie, Keiichi ^a   Hiramatsu, Yukihiro ^a   Sharmin, Tanjina ^a   Fukumitsu, Yuki ^a   Uyeda, Saori ^a   Yamada, Seitaro ^b   Harakuni, Tetsuya ^b   Miyata, Takeshi ^b   Arakawa, Takeshi ^b   Imoto, Masumi ^c   Toda, Akihisa ^c   Nakashima, Yukihiko ^a   Miake, Fumio ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Cholera toxin B subunit; Expression; GM1 ganglioside; Lactic acid bacteria; Oral cholera vaccine; Secretion

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; DRUG CARRIER; GANGLIOSIDE GM1; RECOMBINANT CHOLERA TOXIN B SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; CTB GENE; DOWN REGULATION; DRUG PROTEIN BINDING; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHOLERA TOXIN; CHOLERA VACCINES; ESCHERICHIA COLI; FEMALE; GANGLIOSIDES; IMMUNOGLOBULIN G; LACTOBACILLUS; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT PROTEINS;

EID: 84878887270     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-01021     Document Type: Article

References (25)

1. Yigang XU, Yijing LI. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization. Immunology, 124, 68-75 (2008).
2. Welman AD, Maddox IS. Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol., 21, 269-274 (2003).
3. del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, Gomes-Solecki M. Oral immunization with recombinant Lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin. Vaccine Immunol., 15, 1429-1435 (2008).
4. Jung SW, Kim WJ, Lee KG, Kim CW, Noh WS. Fermentation characteristics of exopolysaccharide-producing lactic acid bacteria from sourdough and assessment of the isolates for industrial potential. J. Microbiol. Biotechnol., 18, 1266-1273 (2008).
5. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, Pestel J, Jacquet A. Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy, 64, 406-414 (2009).
6. Shamini G, Ravichandran M, Sinnott JT, Somboonwit C, Sidhu HS, Shapshak P, Kangueane P. Structural inferences for cholera toxin mutations in Vibrio cholerae. Bioinformation, 6, 1-9 (2011).
7. Sharma MK, Singh NK, Jani D, Sisodia R, Thungapathra M, Gautam JK, Meena LS, Singh Y, Ghosh A, Tyagi AK, Sharma AK. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Rep., 27, 307-318 (2008).
8. Kim YS, Kim MY, Kim TG, Yang MS. Expression and assembly of cholera toxin B subunit (CTB) in transgenic carrot (Daucus carota L.). Mol. Biotechnol., 41, 8-14 (2009).
9. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. U.S.A., 104, 10986-10991 (2007).
10. Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J. Dairy Sci., 82, 649-660 (1999).
11. Slos P, Dutot P, Reymund J, Kleinpeter P, Prozzi D, Kieny MP, Delcour J, Mercenier A, Hols P. Production of cholera toxin B subunit in Lactobacillus. FEMS Microbiol. Lett., 169, 29-36 (1998).
12. Senba M, Kashige N, Nakashima Y, Miake F, Watanabe K. Cloning of the gene of beta-N-acetylglucosaminidase from Lactobacillus casei ATCC 27092 and characterization of the enzyme expressed in Escherichia coli. Biol. Pharm. Bull., 23, 527-531 (2000).
13. Kim SF, Baek SJ, Pack MY. Cloning and nucleotide sequence of the Lactobacillus casei lactate dehydrogenase gene. Appl. Environ. Microbiol., 57, 2413-2417 (1991).
14. Pouwels PH, Leer RJ, Shaw M, Heijne den Bak-Glashouwer MJ, Tielen FD, Smit E, Martinez B, Jore J, Conway PL. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol., 41, 155-167 (1998).
15. Llopis M, Antolin M, Carol M, Borruel N, Casellas F, Martinez C, Espín-Basany E, Guarner F, Malagelada JR. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm. Bowel Dis., 15, 275-283 (2009).
16. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. Care Med., 175, 561-569 (2007).
17. van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L, Bienenstock J. Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am. J. Physiol. Regul. Integr. Comp. Physiol., 295, 1131-1137 (2008).
18. Ohkouchi K, Kawamoto S, Tatsugawa K, Yoshikawa N, Takaoka Y, Miyauchi S, Aki T, Yamashita M, Murooka Y, Ono K. Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen. J. Biosci. Bioeng., 113, 536-541 (2012).
19. Oozeer R, Furet JP, Goupil-Feuillerat N, Anba J, Mengaud J, Corthier G. Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice. Appl. Environ. Microbiol., 71, 1356-1363 (2005).
20. Taguchi H, Ohta T. d-Lactate dehydrogenase is a member of the d-isomer-specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in Escherichia coli of the d-lactate dehydrogenase gene of Lactobacillus plantarum. J. Biol. Chem., 266, 12588-12594 (1991).
21. Kawamura YI, Kawashima R, Shirai Y, Kato R, Hamabata T, Yamamoto M, Furukawa K, Fujihashi K, McGhee JR, Hayashi H, Dohi T. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur. J. Immunol., 33, 3205-3212 (2003).
22. Spangler BD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev., 56, 622-647 (1992).
23. 2+ ion. Protein Eng., 11, 577-581 (1998).
24. van Ginkel FW, Jackson RJ, Yoshino N, Hagiwara Y, Metzger DJ, Connell TD, Vu HL, Martin M, Fujihashi K, McGhee JR. Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract. Infect. Immun., 73, 6892-6902 (2005).
25. Wiedermann U, Jahn-Schmid B, Lindblad M, Rask C, Holmgren J, Kraft D, Ebner C. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int. Immunol., 11, 1717-1724 (1999).